SIMULATIONS PLUS, INC.

SLP · NASDAQ

Computer Systems Design Services

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. The company's technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide.

Market Data

Price $12.44 +0.11 (+0.89%)

Market Cap$251M

P/E Ratio—

EPS$—

52W High$36.45

52W Low$11.16

Beta1.20

Data from Finnhub · Updated Mar 15, 2026